Cargando…

Severe hyperphosphatemia in a patient with chronic kidney disease and multiple myeloma–to strengthen the case toward renal replacement therapy?

KEY CLINICAL MESSAGE: We report a patient with multiple myeloma and chronic kidney disease who presented with severe hyperphosphatemia in the outpatient clinic without any related symptoms. Initial differential diagnosis: Tumor lysis syndrome or chronic kidney disease. Further work-up revealed pseud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Latus, Joerg, Höring, Elisabeth, Voehringer, Matthias, Ratge, Dieter, Alscher, M Dominik, Braun, Niko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BlackWell Publishing Ltd 2013
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184753/ https://www.ncbi.nlm.nih.gov/pubmed/25356216 http://dx.doi.org/10.1002/ccr3.31

Ejemplares similares

Puumala Hantavirus-Induced Hemorrhagic Fever with Renal Syndrome Must Be Considered across the Borders of Nephrology to Avoid Unnecessary Diagnostic Procedures
por: Kitterer, Daniel, et al.
Publicado: (2015)

Ethylene glycol poisoning: a rare but life-threatening cause of metabolic acidosis—a single-centre experience
por: Latus, Joerg, et al.
Publicado: (2012)

The number of patients with severe encapsulating peritoneal sclerosis is decreasing in a large referral center in Germany
por: Kitterer, Daniel, et al.
Publicado: (2016)

Successful Antiviral Triple Therapy in a Longstanding Refractory Hepatitis C Virus Infection with an Acute Kidney Injury
por: Callau Monje, David, et al.
Publicado: (2014)

Early Stages of Calciphylaxis: Are Skin Biopsies the Answer?
por: Latus, Joerg, et al.
Publicado: (2011)

Evaluation of lipase levels in patients with nephropathia epidemica - no evidence for acute pancreatitis
por: Kitterer, Daniel, et al.
Publicado: (2015)

The Potential Role of NFAT5 and Osmolarity in Peritoneal Injury
por: Seeger, Harald, et al.
Publicado: (2015)

Alteration of membrane complement regulators is associated with transporter status in patients on peritoneal dialysis
por: Kitterer, Daniel, et al.
Publicado: (2017)

Cholestatic Liver Disease after Rituximab and Adalimumab and the Possible Role of Cross-Reacting Antibodies to Fab 2 Fragments
por: Latus, Joerg, et al.
Publicado: (2013)

Impact of long-term steroid therapy on epicardial and pericardial fat deposition: a cardiac MRI study
por: Kitterer, Daniel, et al.
Publicado: (2015)

Incidence of and risk factors for hungry bone syndrome in 84 patients with secondary hyperparathyroidism
por: Latus, Joerg, et al.
Publicado: (2013)

C-reactive protein levels in combination with abdominal CT scans is a useful tool to predict the macroscopic appearance in late-stage EPS patients prior to surgery
por: Kitterer, Daniel, et al.
Publicado: (2015)

Detection of Puumala Hantavirus Antigen in Human Intestine during Acute Hantavirus Infection
por: Latus, Joerg, et al.
Publicado: (2014)

Microbiological Surveillance of Peritoneal Dialysis Associated Peritonitis: Antimicrobial Susceptibility Profiles of a Referral Center in GERMANY over 32 Years
por: Kitterer, Daniel, et al.
Publicado: (2015)

Histological Criteria for Encapsulating Peritoneal Sclerosis – A Standardized Approach
por: Braun, Niko, et al.
Publicado: (2012)

T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides
por: Greulich, Simon, et al.
Publicado: (2017)

Phosphate intake, hyperphosphatemia, and kidney function
por: Rubio-Aliaga, Isabel, et al.
Publicado: (2022)

Evaluation of methods to eliminate analytical interference in multiple myeloma patients with spurious hyperphosphatemia
por: Tian, Xin, et al.
Publicado: (2023)

Should we recommend precautions during a hantavirus endemic?
por: Kimmel, Martin, et al.
Publicado: (2010)

Evaluation of myocardial involvement in patients with connective tissue disorders: a multi-parametric cardiovascular magnetic resonance study
por: Mayr, Agnes, et al.
Publicado: (2016)

Advanced myocardial tissue characterisation by a multi-component CMR protocol in patients with rheumatoid arthritis
por: Greulich, Simon, et al.
Publicado: (2017)

Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy
por: Bolignano, Davide, et al.
Publicado: (2022)

Hyperphosphatemia and Cardiovascular Disease
por: Zhou, Chao, et al.
Publicado: (2021)

Histological and Clinical Findings in Patients with Post-Transplantation and Classical Encapsulating Peritoneal Sclerosis: A European Multicenter Study
por: Latus, Joerg, et al.
Publicado: (2014)

Hyperphosphatemia: The hidden killer in chronic kidney disease
por: Askar, Akram M.
Publicado: (2015)

Hyperphosphatemia Management in Patients with Chronic Kidney Disease
por: Shaman, Ahmed M., et al.
Publicado: (2016)

The Spectrum of Podoplanin Expression in Encapsulating Peritoneal Sclerosis
por: Braun, Niko, et al.
Publicado: (2012)

Underutilization of information and knowledge in everyday medical practice: Evaluation of a computer-based solution
por: Zakim, David, et al.
Publicado: (2008)

Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective
por: Reddy, Yogesh NV, et al.
Publicado: (2014)

Hyperphosphatemia and risks of acute kidney injury, end-stage renal disease, and mortality in hospitalized patients
por: Moon, Hongran, et al.
Publicado: (2019)

Transcriptional Patterns in Peritoneal Tissue of Encapsulating Peritoneal Sclerosis, a Complication of Chronic Peritoneal Dialysis
por: Reimold, Fabian R., et al.
Publicado: (2013)

Management of hyperphosphatemia in patients with end-stage renal disease: focus on lanthanum carbonate
por: Persy, Veerle P, et al.
Publicado: (2009)

Computerized history-taking as a tool to manage dyslipidemia
por: Zakim, David, et al.
Publicado: (2010)

Angiogenesis and cellularity in encapsulating peritoneal sclerosis
por: Braun, Niko, et al.
Publicado: (2010)

The management of hyperphosphatemia by lanthanum carbonate in chronic kidney disease patients
por: Shigematsu, Takashi, et al.
Publicado: (2012)

Severe Hyperphosphatemia in a Patient with Mild Acute Kidney Injury
por: Pham, Phuong Chi, et al.
Publicado: (2021)

Effect of Intradialytic Exercise on Hyperphosphatemia and Malnutrition
por: Salhab, Nada, et al.
Publicado: (2019)

Control of hyperphosphatemia and maintenance of calcemia in CKD
por: Carvalho, Aluizio Barbosa, et al.
Publicado: (2021)

Effect of low dose nicotinic acid on hyperphosphatemia in patients with end stage renal disease
por: Zahed, N. S., et al.
Publicado: (2016)

Clinical Course and Long-Term Outcome of Hantavirus-Associated Nephropathia Epidemica, Germany
por: Latus, Joerg, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_menadkojmhj783p6jut86gqmkn